Skip to main navigation

Top bar

Biogen.com Information Request Sign up for Alerts Search

Investor Relations

Overview

News

Events Presentations

SEC Filings Annual Reports

Stock Quote & Chart Analyst Coverage Investor FAQs

Governance Documents Committee Composition & Charters Leadership Code of Business Conduct Contact the Board

News

News

News Category

Year

April 9, 2021

Biogen Announces Two New Nominees for Election to Board of Directors

April 9, 2021

Biogen to Report First Quarter 2021 Financial Results April 22, 2021

April 8, 2021

Biogen and Bio-Thera Solutions Announce Commercialization and License Agreement for Proposed Biosimilar Currently in Phase 3 With the Potential to Treat Moderate to Severe Rheumatoid Arthritis

April 7, 2021

The European Commission Grants Marketing Authorization for New Subcutaneous Administration of TYSABRI® (natalizumab) to Treat Relapsing-Remitting Multiple Sclerosis

March 22, 2021

Biogen to Participate in the Stifel 3rd Annual CNS Day

March 4, 2021

Biogen Announces Plans to Build a New, State-of-the-Art Gene Therapy Manufacturing Facility in Research Triangle Park, North Carolina

March 3, 2021

Biogen to Webcast Aducanumab Presentations from AD/PD 2021 Virtual Conference on March 9-13, 2021

February 24, 2021

Life Science Cares and Biogen Foundation Help Launch Food For Free’s Just Eats Program

February 22, 2021

Biogen to Participate in the Cowen 41st Annual Health Care Conference

February 19, 2021

Biogen to Participate in Webinar with the Global Alzheimer's Platform Foundation on February 23, 2021

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 1 - 10 of 783

Footer

Investors
Careers
Our Stories
Contact Us

Follow us

Bottom

Privacy Policy
Terms & Conditions
Forward-Looking Statements
Community Guidelines

Investor Relations

Overview

News

Events & Presentations

Events
Presentations

Financials

SEC Filings
Annual Reports

Stock Information

Stock Quote & Chart
Analyst Coverage
Investor FAQs

Corporate Governance

Governance Documents
Committee Composition & Charters
Leadership
Code of Business Conduct
Contact the Board

Top bar

Biogen.com

Information Request

Sign up for Alerts

Search

Follow us